1-4 of 4
Robert O. Carpenter
Close
Sort by
Journal Articles

Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation

James N. Kochenderfer, Mark E. Dudley, Robert O. Carpenter, Sadik H. Kassim, Jeremy J. Rose, William G. Telford, Frances T. Hakim, David C. Halverson, Daniel H. Fowler, Nancy M. Hardy, Anthony R. Mato, Dennis D. Hickstein, Juan C. Gea-Banacloche, Steven Z. Pavletic, Claude Sportes, Irina Maric, Steven A. Feldman, Brenna G. Hansen, Jennifer S. Wilder, Bazetta Blacklock-Schuver, Bipulendu Jena, Michael R. Bishop, Ronald E. Gress, Steven A. Rosenberg
Journal: Blood
Blood (2013) 122 (25): 4129–4139.
https://doi.org/10.1182/blood-2013-08-519413
Published: 2013
Includes: Supplemental data
Journal Articles

Effective Treatment Of Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma With Autologous T Cells Genetically-Engineered To Express An Anti-CD19 Chimeric Antigen Receptor

James N. Kochenderfer, M.D., Mark E. Dudley, Ph.D., Sadik H. Kassim, Ph.D., Robert O. Carpenter, James C. Yang, MD, Giao Q. Phan, MD, Marybeth S. Hughes, MD, Richard M. Sherry, MD, Steven Feldman, Ph.D., David Spaner, MD, PhD, Debbie-Ann N. Nathan, RN, Kathleen E. Morton, RN, Mary Ann Toomey, RN, Steven A. Rosenberg, M.D., Ph.D.
Journal: Blood
Blood (2013) 122 (21): 168.
https://doi.org/10.1182/blood.V122.21.168.168
Published: 2013
Journal Articles

Donor-Derived Anti-CD19 Chimeric-Antigen-Receptor-Expressing T Cells Cause Regression Of Malignancy Persisting After Allogeneic Hematopoietic Stem Cell Transplantation

James N Kochenderfer, M.D., Mark E. Dudley, Ph.D., Robert O. Carpenter, Sadik H Kassim, Ph.D., Jeremy J. Rose, William Telford, Ph.D., Frances T Hakim, PhD, David Halverson, MD, Daniel H. Fowler, MD, Nancy M. Hardy, MD, Anthony Mato, Dennis D. Hickstein, M.D., Juan Gea-Banacloche, MD, Steven Z. Pavletic, MD, Claude Sportes, MD, Irina Maric, MD, Steven Feldman, Ph.D., Brenna G Hansen, RN, Jennifer Wilder, RN, Bazetta Blacklock-Schuver, RN, Bipulendu Jena, PhD, Michael Bishop, MD, Steven A. Rosenberg, M.D., Ph.D., Ronald E. Gress, MD
Journal: Blood
Blood (2013) 122 (21): 151.
https://doi.org/10.1182/blood.V122.21.151.151
Published: 2013
Journal Articles

B-Cell Maturation Antigen Is a Promising Target for Genetically-Modified T-Cell Therapy of Multiple Myeloma

Robert O. Carpenter, Moses O. Evbuomwan, Stefania Pittaluga, Jeremy J. Rose, Mark Raffeld, MD, Shicheng Yang, Ronald E. Gress, Frances T. Hakim, MD, James N. Kochenderfer
Journal: Blood
Blood (2012) 120 (21): 937.
https://doi.org/10.1182/blood.V120.21.937.937
Published: 2012